Takeda Canada Inc. — licence 101769, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02461692 | CUVITRU | TAKEDA CANADA INC | Solution | IMMUNOGLOBULIN (HUMAN) 200 MG | Marketed |
| 02467526 | FLEBOGAMMA 10% | INSTITUTO GRIFOLS S.A. | Solution | IMMUNOGLOBULIN (HUMAN) 100 MG | Approved |
| 02467488 | FLEBOGAMMA 5% | INSTITUTO GRIFOLS S.A. | Solution | IMMUNOGLOBULIN (HUMAN) 50 MG | Approved |
| 02486598 | GAMASTAN | GRIFOLS THERAPEUTICS LLC | Solution | IMMUNOGLOBULIN (HUMAN) 18 % | Marketed |
| 02279444 | GAMMAGARD LIQUID | TAKEDA CANADA INC | Solution | IMMUNOGLOBULIN (HUMAN) 10 % | Marketed |
| 02247724 | GAMUNEX | GRIFOLS THERAPEUTICS LLC | Solution | IMMUNOGLOBULIN (HUMAN) 10 G | Marketed |
| 02498251 | HIZENTRA | CSL BEHRING CANADA INC | Solution | IMMUNOGLOBULIN (HUMAN) 200 MG | Marketed |
| 02535424 | HIZENTRA | CSL BEHRING CANADA INC | Solution | IMMUNOGLOBULIN (HUMAN) 200 MG | Marketed |
| 02463067 | HIZENTRA | CSL BEHRING CANADA INC | Solution | IMMUNOGLOBULIN (HUMAN) 200 MG | Marketed |
| 02463059 | HIZENTRA | CSL BEHRING CANADA INC | Solution | IMMUNOGLOBULIN (HUMAN) 200 MG | Marketed |
| 02524406 | HYQVIA | TAKEDA CANADA INC | Solution | IMMUNOGLOBULIN (HUMAN) 30 G; HYALURONIDASE (HUMAN RECOMBINANT) 2400 UNIT | Marketed |
| 02524376 | HYQVIA | TAKEDA CANADA INC | Solution | IMMUNOGLOBULIN (HUMAN) 5 G; HYALURONIDASE (HUMAN RECOMBINANT) 400 UNIT | Marketed |
| 02524368 | HYQVIA | TAKEDA CANADA INC | Solution | IMMUNOGLOBULIN (HUMAN) 2.5 G; HYALURONIDASE (HUMAN RECOMBINANT) 200 UNIT | Marketed |
| 02524392 | HYQVIA | TAKEDA CANADA INC | Solution | IMMUNOGLOBULIN (HUMAN) 20 G; HYALURONIDASE (HUMAN RECOMBINANT) 1600 UNIT | Marketed |
| 02524384 | HYQVIA | TAKEDA CANADA INC | Solution | IMMUNOGLOBULIN (HUMAN) 10 G; HYALURONIDASE (HUMAN RECOMBINANT) 800 UNIT | Marketed |
| 02277921 | IGIVNEX | GRIFOLS THERAPEUTICS LLC | Solution | IMMUNOGLOBULIN (HUMAN) 10 G | Marketed |
| 02267713 | OCTAGAM 5% | OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H | Solution | IMMUNOGLOBULIN (HUMAN) 50 MG | Approved |
| 02304619 | PRIVIGEN | CSL BEHRING CANADA INC | Solution | IMMUNOGLOBULIN (HUMAN) 10 % | Marketed |
| 02494426 | XEMBIFY | GRIFOLS THERAPEUTICS LLC | Solution | IMMUNOGLOBULIN (HUMAN) 20 % | Approved |
| 00083259 | GAMASTAN | CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD. | Liquid | IMMUNOGLOBULIN (HUMAN) 16.5 % | Cancelled Post Market |
| 02230579 | GAMASTAN S/D | GRIFOLS THERAPEUTICS LLC | Solution | IMMUNOGLOBULIN (HUMAN) 18 % | Cancelled Post Market |
| 02229695 | GAMIMUNE N 10% (IV) | TALECRIS BIOTHERAPEUTICS INC | Solution | IMMUNOGLOBULIN (HUMAN) 100 MG | Cancelled Post Market |
| 02178842 | GAMIMUNE N 5% (IV) | TALECRIS BIOTHERAPEUTICS INC | Solution | IMMUNOGLOBULIN (HUMAN) 50 MG | Cancelled Post Market |
| 00559261 | GAMIMUNE N INJ 5% (IV) | CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD. | Liquid | IMMUNOGLOBULIN (HUMAN) 50 MG | Cancelled Post Market |
| 02231471 | GAMMAGARD S/D | TAKEDA CANADA INC | Powder For Solution; Solution; Kit | IMMUNOGLOBULIN (HUMAN) 10 G | Dormant |
| 02231469 | GAMMAGARD S/D | BAXALTA CANADA CORPORATION | Powder For Solution | IMMUNOGLOBULIN (HUMAN) 2.5 G | Cancelled Post Market |
| 02231468 | GAMMAGARD S/D (IV) | BAXTER CORPORATION | Powder For Solution | IMMUNOGLOBULIN (HUMAN) 0.5 G | Cancelled Post Market |
| 01915312 | GAMMAR INJ 165MG/ML | ARMOUR PHARMACEUTICAL CO. | Liquid | IMMUNOGLOBULIN (HUMAN) 165 MG | Cancelled Post Market |
| 02370352 | HIZENTRA | CSL BEHRING CANADA INC | Solution | IMMUNOGLOBULIN (HUMAN) 200 MG | Dormant |
| 02185342 | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 5% | BAYER CORPORATION | Liquid | IMMUNOGLOBULIN (HUMAN) 50 MG | Cancelled Post Market |
| 02230920 | IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 10% | TALECRIS BIOTHERAPEUTICS INC | Solution | IMMUNOGLOBULIN (HUMAN) 10 G | Cancelled Post Market |
| 02230919 | IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 5% | TALECRIS BIOTHERAPEUTICS INC | Solution | IMMUNOGLOBULIN (HUMAN) 5 G | Cancelled Post Market |
| 02230647 | IMMUNE SERUM GLOBULIN (HUMAN) | GRIFOLS THERAPEUTICS LLC | Solution | IMMUNOGLOBULIN (HUMAN) 18 % | Cancelled Post Market |
| 01959301 | IVEEGAM IMMUNO 5000MG (IV) | BAXTER AG | Kit; Powder For Solution; Liquid | IMMUNOGLOBULIN (HUMAN) 5 G; WATER 100 ML | Cancelled Post Market |
| 02380145 | OCTAGAM | OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H | Solution | IMMUNOGLOBULIN (HUMAN) 100 MG | Dormant |
| 02456087 | PANZYGA | OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H | Solution | IMMUNOGLOBULIN (HUMAN) 100 MG | Dormant |
| 02287994 | SANDOGLOBULIN NF LIQUID | CSL BEHRING CANADA INC | Solution | IMMUNOGLOBULIN (HUMAN) 120 G | Cancelled Post Market |